Macro Group’s board approves capital cut

Updated 2/5/2023 11:54:00 AM
Macro Group’s board approves capital cut

Arab Finance: Macro Group Pharmaceutical’s (Macro Capital) (MCRO) board of directors agreed to cut the firm’s issued and paid-up capital to EGP 114.041 million from EGP 115.471 million via writing off 7.152 million shares, according to a statement filed to the Egyptian Exchange (EGX) on February 5th.

Accordingly, the board’s capital cut proposal will be submitted to the extraordinary general meeting (EGM).

Macro Group is a leading Egyptian cosmeceutical company based in Cairo.

Related News